Literature DB >> 22453290

Unravelling fears of genetic discrimination: an exploratory study of Dutch HCM families in an era of genetic non-discrimination acts.

Els Geelen1, Klasien Horstman, Carlo L M Marcelis, Pieter A Doevendans, Ine Van Hoyweghen.   

Abstract

Since the 1990s, many countries in Europe and the United States have enacted genetic non-discrimination legislation to prevent people from deferring genetic tests for fear that insurers or employers would discriminate against them based on that information. Although evidence for genetic discrimination exists, little is known about the origins and backgrounds of fears of discrimination and how it affects decisions for uptake of genetic testing. The aim of this article is to gain a better understanding of these fears and its possible impact on the uptake of testing by studying the case of hypertrophic cardiomyopathy (HCM). In a qualitative study, we followed six Dutch extended families involved in genetic testing for HCM for three-and-a-half years. Semi-structured interviews were conducted with 57 members of these families. Based on the narratives of the families, we suggest that fears of discrimination have to be situated in the broader social and life-course context of family and kin. We describe the processes in which families developed meaningful interpretations of genetic discrimination and how these interpretations affected family members' decisions to undergo genetic testing. Our findings show that fears of genetic discrimination do not so much stem from the opportunity of genetic testing but much more from earlier experiences of discrimination of diseased family members. These results help identify the possible limitations of genetic non-discrimination regulations and provide direction to clinicians supporting their clients as they confront issues of genetic testing and genetic discrimination.

Entities:  

Mesh:

Year:  2012        PMID: 22453290      PMCID: PMC3449067          DOI: 10.1038/ejhg.2012.53

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  24 in total

1.  Getting insurance after genetic screening on familial hypercholesterolaemia; the need to educate both insurers and the public to increase adherence to national guidelines in The Netherlands.

Authors:  P J Marang-van de Mheen; M C van Maarle; M E A Stouthard
Journal:  J Epidemiol Community Health       Date:  2002-02       Impact factor: 3.710

2.  Making genetics not so important: family work in dealing with familial hypertrophic cardiomyopathy.

Authors:  Els Geelen; Ine Van Hoyweghen; Klasien Horstman
Journal:  Soc Sci Med       Date:  2010-06-25       Impact factor: 4.634

3.  Insurance, unfair discrimination, and genetic testing.

Authors:  Patrick J Morrison
Journal:  Lancet       Date:  2005 Sep 10-16       Impact factor: 79.321

4.  In the democracies of DNA: ontological uncertainty and political order in three states.

Authors:  Sheila Jasanoff
Journal:  New Genet Soc       Date:  2005

5.  Congress passes bill to ban discrimination based on individuals' genetic makeup.

Authors:  Tracy Hampton
Journal:  JAMA       Date:  2008-06-04       Impact factor: 56.272

6.  Genetic discrimination in life insurance: empirical evidence from a cross sectional survey of genetic support groups in the United Kingdom.

Authors:  L Low; S King; T Wilkie
Journal:  BMJ       Date:  1998-12-12

7.  Constructing "best interests": genetic testing of children in families with hypertrophic cardiomyopathy.

Authors:  Els Geelen; Ine Van Hoyweghen; Pieter A Doevendans; Carlo L M Marcelis; Klasien Horstman
Journal:  Am J Med Genet A       Date:  2011-07-07       Impact factor: 2.802

8.  Architectures of genetic medicine: comparing genetic testing for breast cancer in the USA and the UK.

Authors:  Shobita Parthasarathy
Journal:  Soc Stud Sci       Date:  2005-02       Impact factor: 3.885

9.  Engagement with genetic discrimination: concerns and experiences in the context of Huntington disease.

Authors:  Yvonne Bombard; Elizabeth Penziner; Oksana Suchowersky; Mark Guttman; Jane S Paulsen; Joan L Bottorff; Michael R Hayden
Journal:  Eur J Hum Genet       Date:  2007-10-24       Impact factor: 4.246

10.  Genetic evaluation of cardiomyopathy--a Heart Failure Society of America practice guideline.

Authors:  Ray E Hershberger; Joann Lindenfeld; Luisa Mestroni; Christine E Seidman; Matthew R G Taylor; Jeffrey A Towbin
Journal:  J Card Fail       Date:  2009-03       Impact factor: 5.712

View more
  10 in total

Review 1.  Global trends on fears and concerns of genetic discrimination: a systematic literature review.

Authors:  Annet Wauters; Ine Van Hoyweghen
Journal:  J Hum Genet       Date:  2016-01-07       Impact factor: 3.172

2.  Public attitudes towards the genetic testing in Georgia.

Authors:  Eka Kvaratskhelia; Davit Chokoshvili; Merab Kvintradze; Sandro Surmava; Ketevan Dzagoevi; Pascal Borry; Elene Abzianidze
Journal:  J Community Genet       Date:  2021-03-30

3.  Genetic testing and insurance implications: Surveying the US general population about discrimination concerns and knowledge of the Genetic Information Nondiscrimination Act (GINA).

Authors:  Anya E R Prince; Wendy R Uhlmann; Sonia M Suter; Aaron M Scherer
Journal:  Risk Manag Insur Rev       Date:  2021-11-19

4.  Study protocol: the Australian genetics and life insurance moratorium-monitoring the effectiveness and response (A-GLIMMER) project.

Authors:  Louise Keogh; Paul Lacaze; Jane Tiller; Aideen McInerney-Leo; Andrea Belcher; Tiffany Boughtwood; Penny Gleeson; Martin Delatycki; Kristine Barlow-Stewart; Ingrid Winship; Margaret Otlowski
Journal:  BMC Med Ethics       Date:  2021-05-21       Impact factor: 2.652

5.  Epigenome data release: a participant-centered approach to privacy protection.

Authors:  Stephanie O M Dyke; Warren A Cheung; Yann Joly; Ole Ammerpohl; Pavlo Lutsik; Mark A Rothstein; Maxime Caron; Stephan Busche; Guillaume Bourque; Lars Rönnblom; Paul Flicek; Stephan Beck; Martin Hirst; Henk Stunnenberg; Reiner Siebert; Jörn Walter; Tomi Pastinen
Journal:  Genome Biol       Date:  2015-07-17       Impact factor: 13.583

6.  Life insurance: genomic stratification and risk classification.

Authors:  Yann Joly; Hilary Burton; Bartha Maria Knoppers; Ida Ngueng Feze; Tom Dent; Nora Pashayan; Susmita Chowdhury; William Foulkes; Alison Hall; Pavel Hamet; Nick Kirwan; Angus Macdonald; Jacques Simard; Ine Van Hoyweghen
Journal:  Eur J Hum Genet       Date:  2013-10-16       Impact factor: 4.246

Review 7.  Incorporating genomics into breast and prostate cancer screening: assessing the implications.

Authors:  Susmita Chowdhury; Tom Dent; Nora Pashayan; Alison Hall; Georgios Lyratzopoulos; Nina Hallowell; Per Hall; Paul Pharoah; Hilary Burton
Journal:  Genet Med       Date:  2013-02-14       Impact factor: 8.822

8.  Benefits and Risks of Sharing Genomic Data for Research: Comparing the Views of Rare Disease Patients, Informal Carers and Healthcare Professionals.

Authors:  Mariana Amorim; Susana Silva; Helena Machado; Elisa Leão Teles; Maria João Baptista; Tiago Maia; Ngozi Nwebonyi; Cláudia de Freitas
Journal:  Int J Environ Res Public Health       Date:  2022-07-19       Impact factor: 4.614

9.  'You should at least ask'. The expectations, hopes and fears of rare disease patients on large-scale data and biomaterial sharing for genomics research.

Authors:  Pauline McCormack; Anna Kole; Sabina Gainotti; Deborah Mascalzoni; Caron Molster; Hanns Lochmüller; Simon Woods
Journal:  Eur J Hum Genet       Date:  2016-04-06       Impact factor: 4.246

Review 10.  Ethical aspects of sudden cardiac arrest research using observational data: a narrative review.

Authors:  Marieke A R Bak; Marieke T Blom; Hanno L Tan; Dick L Willems
Journal:  Crit Care       Date:  2018-09-13       Impact factor: 9.097

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.